- Home
- PRTC vs FRA Comparison
PRTC vs FRA Comparison
Compare PRTC & FRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRTC
- FRA
- Stock Information
- Founded
- PRTC 2015
- FRA 2003
- Country
- PRTC United States
- FRA United States
- Employees
- PRTC N/A
- FRA N/A
- Industry
- PRTC Biotechnology: Pharmaceutical Preparations
- FRA Investment Bankers/Brokers/Service
- Sector
- PRTC Health Care
- FRA Finance
- Exchange
- PRTC Nasdaq
- FRA Nasdaq
- Market Cap
- PRTC 439.8M
- FRA 449.1M
- IPO Year
- PRTC N/A
- FRA N/A
- Fundamental
- Price
- PRTC N/A
- FRA $13.25
- Analyst Decision
- PRTC Buy
- FRA
- Analyst Count
- PRTC 1
- FRA 0
- Target Price
- PRTC $45.00
- FRA N/A
- AVG Volume (30 Days)
- PRTC 5.9K
- FRA 165.4K
- Earning Date
- PRTC 08-27-2025
- FRA 01-01-0001
- Dividend Yield
- PRTC N/A
- FRA 11.06%
- EPS Growth
- PRTC N/A
- FRA N/A
- EPS
- PRTC 0.21
- FRA N/A
- Revenue
- PRTC $4,828,000.00
- FRA N/A
- Revenue This Year
- PRTC $35.98
- FRA N/A
- Revenue Next Year
- PRTC $115.38
- FRA N/A
- P/E Ratio
- PRTC $7.93
- FRA N/A
- Revenue Growth
- PRTC 44.98
- FRA N/A
- 52 Week Low
- PRTC $13.30
- FRA $11.33
- 52 Week High
- PRTC $25.00
- FRA $13.10
- Technical
- Relative Strength Index (RSI)
- PRTC 43.39
- FRA 71.21
- Support Level
- PRTC $16.50
- FRA $12.85
- Resistance Level
- PRTC $18.40
- FRA $12.96
- Average True Range (ATR)
- PRTC 0.45
- FRA 0.10
- MACD
- PRTC -0.17
- FRA 0.03
- Stochastic Oscillator
- PRTC 20.88
- FRA 84.91
About PRTC PureTech Health plc
PureTech Health PLC, together with its subsidiaries, is a clinical-stage biopharma company developing medicines to modulate the adaptive human system. The company is focused on developing and commercializing differentiated medicines for devastating diseases, including inflammatory, immunological conditions, intractable cancers, lymphatic & gastrointestinal diseases, and neurological and neuropsychological disorders, among others. Its drug development pipeline consists of Deupirfenidone (LYT-100), for the potential treatment of idiopathic pulmonary fibrosis (IPF), LYT-200, SPT-300, an oral drug for depressive disorder, SPT-320, and others. The company's operating segments include Parent Companies & Other, which derives key revenue, Wholly-Owned Programs, and Controlled Founded Entities.
About FRA Blackrock Floating Rate Income Strategies Fund Inc
Blackrock Floating Rate Inc Stra Fd Inc is a United States-based diversified closed-ended management investment company. The Fund's investment objective is to provide shareholders with high current income and preservation of capital with investment in a diversified, leveraged portfolio consisting of floating-rate debt securities and instruments.